← Evidence map

ArticlePloS one2013

Ponatinib is a pan-BCR-ABL kinase inhibitor: MD simulations and SIE study.

Karunakar Tanneeru et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

15 papers cite it

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 24236021